Live from the NIH registry
Studies recruiting near Orlando right now
Top 25 of 973 recruiting studies, sorted by proximity — each links to its official registry page
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
AdventHealth Orlando — Orlando, Florida (4.9 mi)
· Sponsor: Syndax Pharmaceuticals
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
Helicobacter Pylori, Safety
Phase 3
Interventional 40 participants sought
Orlando Health, Inc. — Orlando, Florida (4.9 mi)
· Sponsor: ARJ Medical, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (4.9 mi)
· Sponsor: National Cancer Institute (NCI)
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Research Institute of Orlando, LLC — Orlando, Florida (4.9 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Ulcerative Colitis
Phase 2
Interventional 224 participants sought
Clinical Research of Osceola, LLC — Kissimmee, Florida (12.9 mi)
· Sponsor: Genentech, Inc.
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Large B-cell Lymphoma, Lymphoma, B-Cell
Phase 3
Interventional 400 participants sought
AdventHealth — Orlando, Florida (4.9 mi)
· Sponsor: Lyell Immunopharma, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Conquest Research — Winter Park, Florida (8.5 mi)
· Sponsor: Annovis Bio Inc.
A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
Advanced Renal Cell Carcinoma (RCC)
Phase 1, Phase 2
Interventional 474 participants sought
Local Institution - 0126 — Orlando, Florida (4.9 mi)
· Sponsor: Bristol-Myers Squibb
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Phase 2
Interventional 113 participants sought
Central Florida Pulmonary Group — Orlando, Florida (4.9 mi)
· Sponsor: Anagram Therapeutics, Inc.
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Orlando — Maitland, Florida (10.5 mi)
· Sponsor: RAI Services Company
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Advent Health Orlando — Orlando, Florida (4.9 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
CTR Oakwater LLC — Orlando, Florida (4.9 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
Neuroblastoma
Phase 2
Interventional 93 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (4.9 mi)
· Sponsor: Giselle Sholler
Observational Study Protocol: LIVER-R
Hepatobiliary Cancers
N/A
Observational 4,000 participants sought
Research Site — Clermont, Florida (26.9 mi)
· Sponsor: AstraZeneca
Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Neuroblastoma
Phase 2
Interventional 98 participants sought
Arnold Palmer Hospital for Children — Orlando, Florida (4.9 mi)
· Sponsor: Giselle Sholler
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
Chronic Migraine
Phase 3
Interventional 420 participants sought
Pediatric Neurology & Epilepsy Center Of Central Florida - Winter Park /ID# 275263 — Winter Park, Florida (8.5 mi)
· Sponsor: AbbVie
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
Prostate Cancer
Phase 3
Interventional 940 participants sought
AdventHealth — Orlando, Florida (4.9 mi)
· Sponsor: Novartis Pharmaceuticals
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Orlando, Florida (4.9 mi)
· Sponsor: Sameek Roychowdhury
A Study of T3011 in Patients With BCG-Unresponsive NMIBC or BCG-Exposed, Chemotherapy-Unresponsive NMIBC
Nonmuscle-invasive Bladder Cancer
Phase 2
Interventional 160 participants sought
Advent Health Medical Group Urology — Orlando, Florida (4.9 mi)
· Sponsor: ImmVira Pharma Co. Ltd
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
Non-Small Cell Lung Cancer (NSCLC)
Phase 3
Interventional 750 participants sought
Clermont Oncology Center — Clermont, Florida (26.9 mi)
· Sponsor: Bristol-Myers Squibb
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Small Cell Lung Cancer
Phase 3
Interventional 400 participants sought
University of Florida Health Cancer Center at Orlando Health — Orlando, Florida (4.9 mi)
· Sponsor: Amgen
Study to Assess the Effect and Safety of ALV-100 on Maintenance of Weight Loss
Overweight , Obesity, Adults
Phase 2
Interventional 220 participants sought
Clinical Neuroscience Solutions — Orlando, Florida (4.9 mi)
· Sponsor: Alveus Therapeutics, Inc.
Tagraxofusp and Azacitidine With Venetoclax in Newly Diagnosed Secondary AML After Hypomethylating Agents
Acute Myeloid Leukemia
Phase 2
Interventional 53 participants sought
AdventHealth Orlando — Orlando, Florida (4.9 mi)
· Sponsor: Joshua Zeidner
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
Advanced Prostate Cancer, Metastatic Prostate Cancer
Phase 1
Interventional 210 participants sought
Sarah Cannon Research Institute @ Florida Cancer — Orlando, Florida (4.9 mi)
· Sponsor: Genentech, Inc.
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
Non-Small Cell Lung Cancer
Phase 3
Interventional 675 participants sought
Research Site — Orlando, Florida (4.9 mi)
· Sponsor: AstraZeneca